Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 6,101–6,125 of 27,380 studies, newest first · page 245 of 1096.

October 2024 25

  1. 2024-10-20

    Early detection of dementia through retinal imaging and trustworthy AI

    ✓ Peer-reviewed Brain scans and imaging NPJ digital medicine

    Key finding: Using 5751 OCTA images from 1671 participants in a multi-center study, our model demonstrated superior performance in EOAD (internal data: AUC = 0.9355, external data: AUC = 0.9007) and MCI detection (internal data: AUC = 0.8630, external data: AUC = 0.8037). +2 more findings

  2. 2024-10-20

    Exploring Neighborhood-Level Environmental Justice to Tackle County-Level Disparities in Breast Cancer Outcomes

    ✓ Peer-reviewed Risk factors Scholarly Review Journal

    Key finding: This examination revealed higher incidences of breast cancer in Latinx and African American communities with high environmental exposures and lower socioeconomic statuses.

  3. 2024-10-19

    Alterations of the pulvinar in posterior cortical atrophy: A multimodal MRI study

    ✓ Peer-reviewed Brain scans and imaging Cortex; a journal devoted to the study of the nervous system and behavior

    Key finding: Cognitive and visual functions including visuospatial processing, visual perception, episodic memory, and naming were impaired among PCA patients. +4 more findings

  4. 2024-10-19

    Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Neurobiology of aging

    Key finding: Both APPSAA-KI and hAβ-KI mice exhibit cognitive impairments, wherein no significant differences are found between these two models, although APPSAA KI mice show a trend towards worse cognitive function. +2 more findings

  5. 2024-10-19

    Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study

    ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy

    Key finding: In 320 patients, baseline plasma NfL levels were negatively associated with global cognition (β=-1.28 (-1.81 ; -0.75) P < 0.001), memory (β=-1.48 (-2.38 ; -0.59), P = 0.001), language (β=-1.72(-2.49 ; -0.95) P < 0.001), praxis (β=-2.02 (-2.91 ; -1.13) P < 0.001) and executive functions (β=-0.81, P < 0.001). +4 more findings

  6. 2024-10-18

    Brain-targeting liposome-based APOE2 gene delivery exacerbates soluble amyloid-β accumulation in App NL-G-F mice

    ✓ Peer-reviewed Genetics Heliyon

    Key finding: APOE regulates brain lipid homeostasis and maintaining synaptic plasticity and neuronal function, where APOE2 has a superior function compared to APOE3 and APOE4. +3 more findings

  7. 2024-10-18

    Effect of a Financial Incentive Scheme for Medication Review on Polypharmacy in Elderly Inpatients With Dementia: A Retrospective Before-and-After Study

    ✓ Peer-reviewed Health systems and care delivery Journal of patient safety

    Key finding: No significant changes were observed in the average number of medication classes at discharge immediately after the introduction of the scheme (coefficient: -0.022, 95% confidence interval [CI]: -0.17 to 0.13). +2 more findings

  8. 2024-10-18

    Nationwide Availability of and Enrollment in Medicare and Medicaid Dual-Eligible Special Needs Plans With Exclusively Aligned Enrollment

    ✓ Peer-reviewed Risk factors JAMA Health Forum

    Key finding: Of 2 197 732 beneficiaries enrolled in D-SNPs in 2021, 881 736 (40.1%) were living in counties with aligned enrollment available and 251 305 (11.4%) enrolled. +4 more findings

  9. 2024-10-17

    Social isolation and social cognition: A cross-sectional analysis

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: No significant association was found between social isolation and ToM abilities for both the unadjusted and adjusted models. +2 more findings

  10. 2024-10-17

    Cognitive reserve in individuals with frontotemporal dementia: a systematic review

    ✓ Peer-reviewed Risk factors Journal of clinical and experimental neuropsychology

    Key finding: Based on the included studies, partial support was demonstrated for CR in individuals with FTD when education, occupation, and leisure were utilized as CR proxies. +1 more finding

  11. 2024-10-17
  12. 2024-10-16

    fMRI-based Alzheimer's disease detection via functional connectivity analysis: a systematic review

    ✓ Peer-reviewed Brain scans and imaging PeerJ. Computer science

    Key finding: Ultimately, the paper analyzed results on AD and highlighted future research directions in medical imaging.

  13. 2024-10-16

    Intervention Development for Tailored Education for Aging and Cognitive Health (TEACH) for Dementia Prevention in Midlife Adults: Protocol for a Randomized Controlled Trial

    ✓ Peer-reviewed Treatments JMIR research protocols

    Key finding: Study findings will reveal the feasibility of delivering an 8-week multidomain health education intervention for primary prevention of dementia in midlife and will provide preliminary evidence of mechanisms of change. +2 more findings

  14. 2024-10-15

    Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia

    ✓ Peer-reviewed Biomarkers JAMA

    Key finding: Plasma biomarkers of AD neuropathology, neuronal injury, and astrogliosis increase with age and are associated with known dementia risk factors. +4 more findings

  15. 2024-10-15
  16. 2024-10-14

    Integrated multimodal cell atlas of Alzheimer's disease

    ✓ Peer-reviewed How common it is Nature neuroscience

    Key finding: Pseudoprogression analysis revealed two disease phases: an early phase with a slow increase in pathology, presence of inflammatory microglia, reactive astrocytes, loss of somatostatin + inhibitory neurons, and a remyelination response by oligodendrocyte precursor cells; and a later phase with exponential increase in pathology, loss of excitatory neurons and Pvalb + and Vip + inhibitory neuron subtypes. +1 more finding

  17. 2024-10-13

    Misfolded alpha synuclein co-occurrence with Alzheimer's disease proteinopathy

    ⚠ Preprint — not yet peer-reviewed Brain tissue and pathology medRxiv : the preprint server for health sciences

    Key finding: Syn positivity (synSAA+) co-occurred with T (in synSAA+ vs synSAA-, 36% vs 20% T+; p=0.011) and with cognitive impairment (10% vs 7% MCI; 10% vs 0% dementia; p=0.00050). synSAA+ participants' cognitive performance declined ∼40% faster than synSAA-for Digit Symbol, but not other tests. +2 more findings

    Scored 45 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  18. 2024-10-13

    Semaglutide ameliorates Alzheimer's disease and restores oxytocin in APP/PS1 mice and human brain organoid models

    ✓ Peer-reviewed Drug development Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    Key finding: Behavioral analyses on APP/PS1 mice demonstrated that Semaglutide improved the cognitive capabilities, particularly in the learning and memory domains. +4 more findings

  19. 2024-10-12

    Head-to-head comparison of leading blood tests for Alzheimer's disease pathology

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: This study identified the plasma biomarker analytes and assays that most accurately classified amyloid pathology and other AD-related outcomes.

  20. 2024-10-11

    Multimodal photoacoustic microscopy and optical coherence tomography ocular biomarker imaging in Alzheimer's disease in mice

    ✓ Peer-reviewed Brain scans and imaging Biomedical optics express

    Key finding: OCT distinguished significant differences in retinal layer thickness between AD and WT animals.

  21. 2024-10-11

    APOE ε4 carrier status moderates the effect of lifestyle factors on cognitive reserve

    ✓ Peer-reviewed Genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Significant interactions were found between APOE ε4 status and mindfulness and social engagement on cognitive reserve, indicating stronger associations for APOE ε4 carriers. +4 more findings

  22. 2024-10-11

    iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta

    ✓ Peer-reviewed Genetics Fluids and barriers of the CNS

    Key finding: Isogenic BMEC-like cells with different APOE genotypes had similar trans-endothelial electrical resistance, tight junction integrity and efflux transporter gene expression. +4 more findings

  23. 2024-10-11
  24. 2024-10-10

    Advances in Blood Biomarkers and Diagnosis Approaches for Neurodegenerative Dementias and Related Diseases

    ✓ Peer-reviewed Biomarkers Journal of integrative neuroscience

    Key finding: Degenerative proteins begin to accumulate before the onset of the symptoms of these diseases, and the early detection of these symptoms can lead to early therapeutic intervention. +4 more findings

  25. 2024-10-10

    Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Molecular neurodegeneration

    Key finding: Our results demonstrate the feasibility and potential of immunoassay-based multiplexing to provide a comprehensive view of AD-associated proteomic changes, consistent with the recently revised biological and diagnostic framework. +4 more findings

Browse the library by subject, with the full score breakdown →